Biochemical assessment of acute and chronic treatment of Paget's bone disease with calcitonin and calcium with and without biphosphonate
- 1 January 1988
- Vol. 9 (1) , 63-66
- https://doi.org/10.1016/8756-3282(88)90028-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Healing of EHDP-induced osteomalacia by calcitoninBone, 1985
- FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASEThe Lancet, 1984
- Sequential treatment of paget's disease with human calcitonin and dichloromethylene diphosphonate (CI2MDP)Metabolic Bone Disease and Related Research, 1984
- Long Term Effects of Dichloromethylene Diphosphonate in Paget's Disease of BoneJournal of Clinical Endocrinology & Metabolism, 1982
- INHIBITION OF DIPHOSPHONATE-BLOCKED BONE MINERALIZATION. EVIDENCE THAT CALCITONIN PROMOTES MINERALIZATIONActa Endocrinologica, 1979
- Treatment of Paget's disease with combined calcitonin and diphosphonate (EHDP)Metabolic Bone Disease and Related Research, 1978
- PAGET'S BONE DISEASE TREATED WITH DIPHOSPHONATE AND CALCITONINThe Lancet, 1976
- Metabolic effects of synthetic salmon calcitonin in Paget's disease of boneMetabolism, 1974
- Response of Paget's disease to porcine and salmon calcitonins: Effects of long-term treatmentThe American Journal of Medicine, 1974
- Effects of Porcine Calcitonin on Calcium Metabolism in Osteoporosis*Journal of Clinical Endocrinology & Metabolism, 1971